Gallowitsch HJ - Search Results

1

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.

Mikosch P, Igerc I, Kudlacek S, Woloszczuk W, Gallowitsch HJ, Kresnik E, Stettner H, Grimm G, Lind P, Pietschmann P. Mikosch P, et al. Among authors: gallowitsch hj. Eur J Clin Invest. 2006 Aug;36(8):566-73. doi: 10.1111/j.1365-2362.2006.01678.x. Eur J Clin Invest. 2006. PMID: 16893379

2

Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism.

Mikosch P, Jauk B, Gallowitsch HJ, Pipam W, Kresnik E, Lind P. Mikosch P, et al. Among authors: gallowitsch hj. Thyroid. 2001 Mar;11(3):257-63. doi: 10.1089/105072501750159679. Thyroid. 2001. PMID: 11327617

3

Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment.

Mikosch P, Obermayer-Pietsch B, Jost R, Jauk B, Gallowitsch HJ, Kresnik E, Leb G, Lind P. Mikosch P, et al. Among authors: gallowitsch hj. Thyroid. 2003 Apr;13(4):347-56. doi: 10.1089/105072503321669839. Thyroid. 2003. PMID: 12804103

4

Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma.

Gallowitsch HJ, Mikosch P, Kresnik E, Starlinger M, Lind P. Gallowitsch HJ, et al. Clin Nucl Med. 1999 Oct;24(10):744-6. doi: 10.1097/00003072-199910000-00002. Clin Nucl Med. 1999. PMID: 10512097

5

18F-FDG-PET in the follow-up of thyroid cancer.

Lind P, Kresnik E, Kumnig G, Gallowitsch HJ, Igerc I, Matschnig S, Gomez I. Lind P, et al. Among authors: gallowitsch hj. Acta Med Austriaca. 2003;30(1):17-21. doi: 10.1046/j.1563-2571.2003.02046.x. Acta Med Austriaca. 2003. PMID: 12558561

6

The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.

Lind P, Gallowitsch HJ. Lind P, et al. Among authors: gallowitsch hj. Acta Med Austriaca. 1996;23(1-2):69-75. Acta Med Austriaca. 1996. PMID: 8767519

7

Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.

Gallowitsch HJ, Kresnik E, Mikosch P, Pipam W, Gomez I, Lind P. Gallowitsch HJ, et al. Nuklearmedizin. 1996 Dec;35(6):230-5. Nuklearmedizin. 1996. PMID: 8976503

8

Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.

Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I. Lind P, et al. Among authors: gallowitsch hj. J Nucl Med. 1997 Mar;38(3):348-52. J Nucl Med. 1997. PMID: 9074515 Free article.

9

Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.

Kresnik E, Gallowitsch HJ, Mikosch P, Molnar M, Pipam W, Gomez I, Lind P. Kresnik E, et al. Among authors: gallowitsch hj. Eur J Nucl Med. 1997 Jul;24(7):716-21. doi: 10.1007/BF00879657. Eur J Nucl Med. 1997. PMID: 9211755

10

Schwannoma of the neck simulating a thyroid nodule.

Mikosch P, Gallowitsch HJ, Kresnik E, Lind P. Mikosch P, et al. Among authors: gallowitsch hj. Thyroid. 1997 Jun;7(3):449-51. doi: 10.1089/thy.1997.7.449. Thyroid. 1997. PMID: 9226218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters